Clinical experience with infliximab biosimilar in psoriasis
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Dermatology"
DOI: 10.1111/bjd.15755
Abstract: biosimilar medicines are biological medicine that have been developed to be highly similar and clinically equivalent to an existing biological medicine. Just as patent expiry for conventional drugs has led to the marketing of generic… read more here.
Keywords: medicine; dermatology; experience infliximab; clinical experience ... See more keywords